We Did The Math SMLF Can Go To $77
ETF Analyst Target Insights: The iShares U.S. Small-Cap Equity Factor ETF (SMLF) has an implied analyst target price of $77.43, indicating a potential upside of 23.59% from its current trading price of $62.65.
Notable Holdings with Upside Potential: Key holdings within SMLF, such as Apogee Therapeutics Inc., Definitive Healthcare Corp., and Vishay Intertechnology, show significant upside to their analyst target prices, suggesting optimism but also raising questions about the validity of these targets.
Trade with 70% Backtested Accuracy
Analyst Views on SMLF

No data
About the author

ETF Analysis: The iShares U.S. Small-Cap Equity Factor ETF (SMLF) has an implied analyst target price of $87.79, indicating a potential upside of 17.66% from its current trading price of $74.61.
Notable Holdings: Key underlying holdings with significant upside potential include Amplitude Inc (40.90% upside), RADCOM Ltd. (35.14% upside), and Cimpress PLC (28.22% upside) based on their respective analyst target prices.
Market Sentiment: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they do not align with current market conditions.
Investor Research: It emphasizes the need for further investor research to assess the validity of analyst targets in light of recent company and industry developments.
ETF Analysis Overview
- Implied Target Price for SMLF: The iShares U.S. Small-Cap Equity Factor ETF (SMLF) has an implied analyst target price of $82.45 per unit, based on its underlying holdings.
- Current Trading Price: SMLF is currently trading at approximately $73.49 per unit, indicating a potential upside of 12.19% according to analysts.
Notable Holdings with Upside Potential
- Udemy Inc (UDMY): UDMY is trading at $6.96 per share, with an average analyst target price of $9.72, suggesting a significant upside of 39.68%.
- Global-E Online Ltd (GLBE): GLBE's recent share price is $34.18, with a target price of $46.77, indicating a potential upside of 36.83%.
- Thermon Group Holdings Inc (THR): THR is priced at $26.47, while analysts expect it to reach a target price of $35.00, representing an upside of 32.23%.
Analyst Target Price Considerations
- Market Sentiment: The disparity between current trading prices and analyst target prices raises questions about whether analysts are justified in their optimism or if they are out of touch with recent developments in the companies and their industries.
- Investor Research: Investors are encouraged to conduct further research to determine the validity of these target prices and the potential for future price adjustments.
ETF Analyst Target Insights: The iShares U.S. Small-Cap Equity Factor ETF (SMLF) has an implied analyst target price of $78.66, indicating a potential upside of 12.65% from its current trading price of $69.82.
Notable Holdings with Upside Potential: Key underlying holdings such as Apogee Therapeutics Inc, Mativ Inc, and Zeta Global Holdings Corp show significant upside potential based on analyst target prices, with expected increases of 97.80%, 71.50%, and 60.32% respectively.
ETF Analyst Target Prices: The iShares U.S. Small-Cap Equity Factor ETF (SMLF) has an implied analyst target price of $77.86 per unit, indicating a potential upside of 16.40% from its current trading price of $66.89.
Notable Holdings with Upside Potential: Key underlying holdings such as Klaviyo Inc, Rhythm Pharmaceuticals Inc, and MakeMyTrip Ltd show significant upside potential based on analyst targets, with expected increases ranging from 17.51% to 24.42%.
ETF Analysis: The iShares U.S. Small-Cap Equity Factor ETF (SMLF) has an implied analyst target price of $77.21, indicating a potential upside of 17.07% from its current trading price of $65.95.
Stock Performance Insights: Notable underlying holdings such as International Game Technology PLC, Warrior Met Coal Inc, and Nexa Resources SA show significant upside potential based on analysts' target prices compared to their recent trading prices.
ETF Analyst Target Insights: The iShares U.S. Small-Cap Equity Factor ETF (SMLF) has an implied analyst target price of $77.43, indicating a potential upside of 23.59% from its current trading price of $62.65.
Notable Holdings with Upside Potential: Key holdings within SMLF, such as Apogee Therapeutics Inc., Definitive Healthcare Corp., and Vishay Intertechnology, show significant upside to their analyst target prices, suggesting optimism but also raising questions about the validity of these targets.








